#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3338	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2179	444.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1690	1690	T	457	T,G	393,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3338	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2179	444.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1424	1424	C	491	C,A	391,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	3338	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2179	444.2	0	HET	.	.	.	C1525T	.	1525	1525	C	1765	1765	C	468	C,T	202,171	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5524	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3771	437.0	0	.	n	.	0	T695C	SNP	695	695	T	1109	1109	C	410	C,T	333,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5524	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3771	437.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2385	2385	C	502	C,A	407,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5524	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3771	437.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2459	2459	A	542	A,C	426,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5524	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3771	437.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3011	3011	C	529	C,A,G	404,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5524	23S	2890	2890	99.93	23S.l6.c17.ctg.1	3771	437.0	0	HET	.	.	.	G1337A	.	1337	1337	G	1751	1751	G	437	G,A	250,105	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	430	folP	855	855	100.0	folP.l15.c4.ctg.1	1743	73.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1112	1114	AGC	91;91;90	A;G;C	75;73;75	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1084	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3564	90.5	1	SNP	p	S91F	1	.	.	271	273	TTC	632	634	TTC	75;75;75	T,G;T;C	62,1;62;65	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1084	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3564	90.5	1	SNP	p	G95N	0	.	.	283	285	GGC	644	646	GGC	76;76;76	G;G;C	65;64;64	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1084	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3564	90.5	1	SNP	p	D95G	1	.	.	283	285	GGC	644	646	GGC	76;76;76	G;G;C	65;64;64	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	444	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1797	74.0	1	SNP	p	G45D	0	.	.	133	135	GGC	708	710	GGC	117;118;118	G;G;C	92;94;91	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	234	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1309	53.3	0	.	n	.	0	A197.	DEL	197	197	A	818	818	A	104	A	79	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1132	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3290	102.7	1	SNP	p	D86N	0	.	.	256	258	GAC	724	726	GAC	139;139;139	G;A,G,T;C	103;95,1,1;104	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1132	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3290	102.7	1	SNP	p	R87W	0	.	.	259	261	CGT	727	729	CGT	140;140;138	C;G;T,G	105;102;101,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1132	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3290	102.7	1	SNP	p	S87R	1	.	.	259	261	CGT	727	729	CGT	140;140;138	C;G;T,G	105;102;101,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1132	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3290	102.7	1	SNP	p	R87I	0	.	.	259	261	CGT	727	729	CGT	140;140;138	C;G;T,G	105;102;101,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1132	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3290	102.7	1	SNP	p	S88P	0	.	.	262	264	TCC	730	732	TCC	137;136;136	T;C;C,A	103;107;106,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	936	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2948	95.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1728	1730	GGC	122;122;123	G;G;C,A	104;102;98,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	748	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2730	82.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1473	1475	GCA	98;98;97	G;C;A	79;79;79	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	748	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2730	82.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1476	1478	ATC	97;97;96	A;T,C;C	83;80,1;82	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	748	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2730	82.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1488	1490	GTG	98;97;99	G,T;T;G	83,1;81;83	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	748	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2730	82.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1488	1490	GTG	98;97;99	G,T;T;G	83,1;81;83	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	748	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2730	82.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1992	1994	ACC	94;94;95	A;C;C	74;74;73	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	748	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2730	82.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2046	2048	GCG	92;91;91	G;C;G	68;64;65	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	748	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2730	82.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2046	2048	GCG	92;91;91	G;C;G	68;64;65	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	748	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2730	82.0	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2169	2171	AGC	87;85;86	A,C;G;C	66,3;68;74	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	748	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2730	82.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2178	2180	GGC	90;89;89	G;G;C	77;77;77	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	748	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2730	82.0	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2196	2198	CCG	91;91;90	C,G;C;G	70,1;73;71	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1056	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3334	94.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1789	1791	CCG	77;78;78	C;C;G	62;66;63	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	564	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2073	81.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	624	624	C	78	C	63	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	666	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1972	99.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	696	698	GAA	144;145;147	G,A;A;A,C	105,1;105;107,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	666	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1972	99.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1107	1109	TCA	121;121;121	T;C;A	94;96;95	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	666	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1972	99.4	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1236	1238	GTG	144;143;142	G;T;G	116;119;114	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	666	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1972	99.4	0	.	p	.	0	L221P	NONSYN	661	663	CTG	1245	1247	CCG	141;142;142	C;C;G	115;120;119	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	666	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1972	99.4	0	.	p	.	0	G255E	NONSYN	763	765	GGA	1347	1349	GAA	140;140;140	G;A;A,C	120;119;115,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	666	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1972	99.4	1	SNP	p	G120K	1	.	.	358	360	AAG	942	944	AAG	133;133;134	A;A;G	110;109;111	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	666	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1972	99.4	1	SNP	p	D121N	0	.	.	361	363	GAC	945	947	GAC	134;134;135	G;A;C	110;109;113	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	666	porB1b	1047	1047	99.14	porB1b.l6.c30.ctg.1	1972	99.4	1	SNP	p	A121D	1	.	.	361	363	GAC	945	947	GAC	134;134;135	G;A;C	110;109;113	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2320	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5096	136.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	338	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1316	76.9	1	SNP	p	V57M	1	.	.	169	171	ATG	663	665	ATG	145;145;145	A;T;G,A	119;117;117,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
